Technique for Uniform Integration of Retinal Cells
Regenerating the retina and the optic nerve is one of the holy grails in
ophthalmology, an endeavor that is still in the nascent phases of study
and investigation at this point. The current study by Johns Hopkins
Medicine researchers, using mouse retinas in vitro, illustrates an
important obstacle to that goal: how to integrate the stem cells
(retinal ganglion cells derived from human embryonic stem cells in this
case) uniformly. In most cases, the many layers of the retina present a
challenge, resulting in clumping of the cells. You can think of them as
teeny, tiny tumors. The research team found, however, that areas of
their in vitro retina model that were breached by incision showed more
uniform integration of the retinal ganglion cells. They hypothesized
that the internal limiting membrane (ILM), the innermost layer of the
retina composed of footplates of Müller cells, could be the limiting
factor. After loosening the ILM with an enzyme and removing it, the
researchers found more normal integration of the retinal ganglion cells
and establishment of new connections to the rest of the retina. This is
one of those studies that seems obvious in hindsight. It makes sense
that the ILM would present a barrier. So what was interesting was to see
the process unfold of what would happen once the ILM was removed.
Toward Reliable Algorithms
Using artificial intelligence to screen retinal diseases is a promising
line of research, with many software algorithms currently in
development. The utility of this technology lies in its ability to
accurately and reliably detect early disease states, a goal that is
constantly improving. The current study examined the effectiveness of
seven artificial intelligence (AI) algorithms in the detection of
diabetic retinopathy, a common ocular complication of diabetes that
could lead to vision loss. The algorithms were compared with human
screeners in a teleretinal screening system, and both of these were
compared to the standard of diagnostic expertise of retina specialists. A
strength of the study is its sample size of nearly 24,000 images, from
two VA health systems in this case. The researchers found much
inconsistency between what is advertised of the algorithms and their
performance in real-world clinical settings, with only one of the seven
algorithms studied performing as well as the human screeners. This study
is especially interesting for two reasons: (1) It highlights the
importance of developing consistent methods in the diagnostic tool kit;
conclusions can only be reliable if the methods are reliable. (2)
Because this study is a kind of meta-analysis of several algorithms, it
demonstrates the value of examining a broad range of information sources
to arrive at the most robust method available. Note that through the
examination of seven different algorithms, one was discovered to be as
reliable as the human screeners, for the particular populations under
study.
Air Pollution Risk in AMD
This observational study from the U.K. investigated the correlation
between air pollution and increased risk of age-related macular
degeneration (AMD), using both subjective and objective measures. The
sample size is exceptionally large, comprising 115,954
UK Biobank study participants, who completed self-reported surveys of
their AMD diagnosis, as formally diagnosed by a doctor. Among these
participants, 52,602
were also assessed of retinal changes via optical coherence tomography
(OCT). Estimates of ambient air pollution were from the BioSHaRE-EU
Environmental Determinants of Health Project, and matched with official
geographic data. In short, this is a robust observational study. The
researchers found that people
in the most polluted areas were at least 8% more likely to report
having AMD. While observational studies cannot confirm cause, the
results are not particularly surprising. Previous research, for example,
identified smoking as a risk factor for AMD. Air pollution can be
thought of as widespread ambient-level "smoking." Again, while the
research team caution that observational studies cannot investigate
mechanism, they suggest that ambient air pollution could be associated
with AMD through oxidative stress and inflammation. Though the results
are not unexpected, nor preventable given the ubiquitous challenge of
air pollution, this study is a good example of a robust observational
study, and highlights the benefit, perhaps even the need, to work toward
better air quality for better health.
Ciliary Body as "Niche" for Eye Tissues
This
study is interesting for two reasons. Firstly, the ciliary body is not
as commonly talked about, unless you specialize in glaucoma, in which
case it is talked about a lot. The ciliary body produces aqueous humor, a
filtrate of blood, that nourishes the tissues of the eye. Glaucoma is a
very complex disease with many contributing factors and consequences,
but where the ciliary body is concerned, if too much aqueous is
produced, it can lead to elevated intraocular pressure and damage to the
optic nerve and other tissues (i.e., glaucoma). This study doesn't take
the perspective of the ciliary body's connection to glaucoma though.
Rather, it examines the ciliary body as a potential "niche" for eye
tissues. The researchers themselves hesitate to call it a reserve for
"stem cells," since previous research had disproved that hypothesis.
However, they promote the hypothesis of a more indirect role of the
ciliary body in maintaining eye tissues by means of the Notch signaling
pathway. The details of the involved proteins are described in the
article, but the synoposis is that the Notch pathway provides signals
that affect the cellular morphogenesis and function of other eye
tissues. In other words, the ciliary body doesn't provide the stem cells
themselves, but rather regulates development of eye tissues through a
signaling pathway. Finally, the research also explored how these
proteins are involved in the functioning of the ciliary body itself.
Vision Testing for Early Detection of Parkinson's
The eye is the window to the soul, and also to neurological and systemic
health, sometimes quite literally. Earlier in my training, I used to be
amazed that funduscopy could detect cardiovascular disease, and then I
was amazed that OCT could detect neurological diseases like Alzheimer's.
Then the list grew and grew of what this window and this most valued
function could allow us to see. The current studies, for example,
correlate vision testing with new MRI scanning techniques in the early
detection of Parkinson's-related cognitive decline. The connection is
very indirect, but
the research team found that Parkinson’s patients with visual
dysfunction had
more decoupling (for our purposes, an MRI-related measure) in
memory-related regions in the temporal lobe. Both studies have small
sample sizes, of 77 and 88 people with Parkinson's disease. And the
connection is very indirect and limited at this point. That being said,
with further development, early detection of Parkinson's disease via
vision testing is encouraging.
Sunday, January 31, 2021
Week in Review: Number 2
Saturday, January 30, 2021
Air Pollution Risk in AMD
Article: Air pollution linked to higher risk of sight loss from AMD
Source: University College London (U.K.), via ScienceDaily
Published: January 26, 2021
Article: Air pollution linked to heightened risk of progressive and irreversible sight loss (AMD)
Source: BMJ Newsroom
Published: January 25, 2021
This observational study from the U.K. investigated the correlation between air pollution and increased risk of age-related macular degeneration (AMD), using both subjective and objective measures. The sample size is exceptionally large, comprising 115,954 UK Biobank study participants, who completed self-reported surveys of their AMD diagnosis, as formally diagnosed by a doctor. Among these participants, 52,602 were also assessed of retinal changes via optical coherence tomography (OCT). Estimates of ambient air pollution were from the BioSHaRE-EU Environmental Determinants of Health Project, and matched with official geographic data. In short, this is a robust observational study. The researchers found that people in the most polluted areas were at least 8% more likely to report having AMD. While observational studies cannot confirm cause, the results are not particularly surprising. Previous research, for example, identified smoking as a risk factor for AMD. Air pollution can be thought of as widespread ambient-level "smoking." Again, while the research team caution that observational studies cannot investigate mechanism, they suggest that ambient air pollution could be associated with AMD through oxidative stress and inflammation. Though the results are not unexpected, nor preventable given the ubiquitous challenge of air pollution, this study is a good example of a robust observational study, and highlights the benefit, perhaps even the need, to work toward better air quality for better health.
My rating of this study: ⭐⭐⭐
Chua SYL, Warwick A, Peto T, et al. "Association of ambient air pollution with age-related macular degeneration and retinal thickness in UK Biobank." British Journal of Ophthalmology. Published online 25 January 2021. https://doi.org/10.1136/bjophthalmol-2020-316218
Monday, January 25, 2021
Vision Testing for Early Detection of Parkinson's
Article: Eye tests predict Parkinson's-linked cognitive decline 18 months ahead
Source: University College London (U.K.), via ScienceDaily and Technology Networks
Published: January 19, 2021
![]() |
Macrostructural white matter changes in Parkinson's disease patients and low visual performance over time |
My rating of this study: ⭐
Zarkali A, McColgan P, Leyland L, et al. "Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease." Movement Disorders. Published online 9 January 2021. https://doi.org/10.1002/mds.28477
Zarkali A, McColgan P, Leyland L, et al. "Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease." Communications Biology. 4(86). 19 January 2021. https://doi.org/10.1038/s42003-020-01622-9
Saturday, January 23, 2021
Toward Reliable Algorithms
Article: AI algorithms detect diabetic eye disease inconsistently
Source: University of Washington Medicine, via NEI
Published: January 5, 2021
![]() |
Relative performance of human grader compared with AI algorithms |
My rating of this study: ⭐⭐⭐
Lee AY, Yanagihara RT, Lee CS, et al. "Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems." Diabetes Care. 44(5): 1168-1175. Published online 5 January 2021. https://doi.org/10.2337/dc20-1877
Wednesday, January 20, 2021
Technique for Uniform Integration of Retinal Cells
Article: A rift in the retina may help repair the optic nerve
Source: Johns Hopkins Medicine, via ScienceDaily, EyeNet, and Ophthalmology Times
Published: January 14, 2021
![]() |
Greater cell density dispersal with enzyme pre-treatment |
My rating of this study: ⭐⭐⭐
Zhang KY, Tuffy C, Mertz JL, et al. "Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells." Stem Cell Reports. 16(1):149-167. 12 January 2021. https://doi.org/10.1016/j.stemcr.2020.12.001
Monday, January 18, 2021
Ciliary Body as "Niche" for Eye Tissues
Article: A Niche for the Eye
Source: Stowers Institute for Medical Research, via Neuroscience News and Research and NEI
Published: January 1, 2021
![]() |
Wild type mouse eye morphology |
My rating of this study: ⭐⭐
Pang J, Le L, Zhou Y, et al. "NOTCH Signaling Controls Ciliary Body Morphogenesis and Secretion by Directly Regulating Nectin Protein Expression." Cell Reports. 34(2):108603. 12 January 2021. https://doi.org/10.1016/j.celrep.2020.108603
Saturday, January 16, 2021
Week in Review: Number 1
Neurological Basis of Charles Bonnet Syndrome
This
is a very interesting study both for scientific and clinical reasons.
The idea to investigate spontaneous "resting-state" fluctuations in the
brain via patients with Charles Bonnet syndrome is excellent. These are
patients who experience visual hallucinations, "phantom vision" if you
will, after losing sight. Their eyes no longer send input to their
brain, but these patients can still "see" with their intact visual
cortex. Of note is the finding that brain wave activity reminiscent of
slow spontaneous fluctuations emerged just before onset of the
hallucination, indicating that the hallucinations were evoked internally
and not from external stimuli. Limitations of the study include its
small sample size of only five patients with Charles Bonnet syndrome.
However, the news coverage of Charles Bonnet syndrome is an excellent
opportunity to call attention to this condition. As you can imagine,
hallucinations can be a frightening and isolating experience. So
awareness of Charles Bonnet syndrome for both trainees and the public
increases assurance if they encounter the situation.
Anti-fibrotic Therapy for Glaucoma
In
this study, researchers at the University of Burmingham in the U.K.
investigated the use of anti-fibrotic low molecular weight
dextran-sulphate (ILB) as a potential therapeutic for open-angle
glaucoma (OAG) in preclinical rodent models. The researchers state,
"[W]e demonstrated that ILB acts, in part, by
downregulating transforming growth factor (TGF) β signaling genes and by
altering gene expression relating to extracellular matrix dynamics,
leading to tissue remodeling, reduced fibrosis and functional tissue
regeneration. These observations indicate the potential of ILB® to
alleviate fibrotic diseases." To my knowledge, that would be a novel
mechanism to treat OAG by reducing fibrosis of the trabecular meshwork. A
major limitation of the approach, however, is that ILB as currently
formulated is delivered by daily subcutaneous injection. The researchers
are planning to work on a topical "shear thinning fluid gel" as a
delivery method.
Early Detection of Cognitive Decline in Type 1 Diabetics
Ocular
Coherence Tomography (OCT) and its most recent additional function of
angiography (OCTA) have been explored in recent years as a means of
early detection of neurodegenerative diseases such as Alzheimer's. The
retina, being an extension of the brain (specifically the diencephalon),
allows for a unique, noninvasive, and comparatively inexpensive view
into conditions that affect the central nervous system. What was new to
me, i.e., what this article introduced me to, is the potential
connection between diabetes and Alzheimer's disease. The researchers
found associations between proliferative diabetic retinopathy (PDR) and
certain memory and psychomotor tasks. The small and somewhat cloistered
study, comprising 129 participants, investigated the link for people
with Type 1 diabetes, but the researchers plan on future studies for the
larger population of people who are affected by Type 2 diabetes.
Ultra-Thin Sensor for Smart Contact Lenses
Smart
contact lenses "could soon become" mainstream for a long time now. I
don't think there is actually anything exciting about this paper. Their
contact lens is a prototype design, from an engineering approach, that
has not progressed to testing in animal (rabbit) models yet. I suppose
thin electrical components would indeed be very important for a device
that would sit against a very sensitive ocular surface, but let's say
that this design is still in a very early phase at this point.
In the News
An
interesting read. A more experienced version of my own thoughts
generally, except for the following: “I sometimes tell a patient with
complex disease, ‘I’ll teach you something about your disease at every
visit, and eventually you’ll have a PhD in glaucoma.’ I’ve even been
known to assign homework.” This is a great joke! And I think it’s a
great example to show the devaluing of doctoral degrees across the
board. Just as it is a rigorous process to earn an MD, it is a rigorous
process to earn a PhD. For one, a PhD requires generating new knowledge,
not merely disseminating existing knowledge that (prior) PhDs have
produced. I don’t want to go as far as to say that it is ironic, but
this is something to be mindful of as well.
In Other News
1) Aphantasia
2) Optical illusions and dogs
3) Magnetic sense in birds
Friday, January 15, 2021
Anti-fibrotic Therapy for Glaucoma
Article: Birmingham research paves the way for new anti-fibrotic therapy for glaucoma
Source: University of Birmingham (U.K.)
Published: January 7, 2021
Article: Novel Anti-fibrotic Therapy for Glaucoma
Source: Genetic Engineering and Biotechnology News
Published: January 8, 2021
In this study, researchers at the University of Burmingham in the U.K. investigated the use of anti-fibrotic low molecular weight dextran-sulphate (ILB) as a potential therapeutic for open-angle glaucoma (OAG) in preclinical rodent models. The researchers state, "[W]e demonstrated that ILB acts, in part, by
downregulating transforming growth factor (TGF) β signaling genes and by
altering gene expression relating to extracellular matrix dynamics,
leading to tissue remodeling, reduced fibrosis and functional tissue
regeneration. These observations indicate the potential of ILB® to alleviate fibrotic diseases." To my knowledge, that would be a novel mechanism to treat OAG by reducing fibrosis of the trabecular meshwork. A major limitation of the approach, however, is that ILB as currently formulated is delivered by daily subcutaneous injection. The researchers are planning to work on a topical "shear thinning fluid gel" as a delivery method.
Edit: Another potential drawback of using anti-fibrotic agents is the possibility of causing tissue damage. For example, use of mitomycin C (MMC) after pterygium excision can sometimes result in corneoscleral melt. At the same time, subconjunctival MMC has been explored in trabeculectomy.
My rating of this study: ⭐⭐
Hill LJ, Botfield HF, Begum G, et al. "ILB® resolves inflammatory scarring and promotes functional tissue repair." npj Regenerative Medicine. 6(3). 7 January 2021. https://doi.org/10.1038/s41536-020-00110-2
Thursday, January 14, 2021
Neurological Basis of Charles Bonnet Syndrome
Article: A Brain Mechanism for 'Vision' in the Blind is Revealed
Source: Weizmann Institute of Science, via ScienceDaily and Technology Networks
Published: January 7, 2021
This is a very interesting study both for scientific and clinical reasons. The idea to investigate spontaneous "resting-state" fluctuations in the brain via patients with Charles Bonnet syndrome is excellent. These are patients who experience visual hallucinations, "phantom vision" if you will, after losing sight. Their eyes no longer send input to their brain, but these patients can still "see" with their intact visual cortex. Of note is the finding that brain wave activity reminiscent of slow spontaneous fluctuations emerged just before onset of the hallucination, indicating that the hallucinations were evoked internally and not from external stimuli. Limitations of the study include its small sample size of only five patients with Charles Bonnet syndrome. However, the news coverage of Charles Bonnet syndrome is an excellent opportunity to call attention to this condition. As you can imagine, hallucinations can be a frightening and isolating experience. So awareness of Charles Bonnet syndrome for both trainees and the public increases assurance if they encounter the situation.
My rating of this study: ⭐⭐
Hahamy A, Wilf M, Rosinl B, et al. "How do the blind ‘see’? The role of spontaneous brain activity in self-generated perception." Brain. 144(1):340–353. January 2021. https://doi.org/10.1093/brain/awaa384
Wednesday, January 13, 2021
Ultra-Thin Sensor for Smart Contact Lenses
Article: Manufacturing process of ultra-thin sensor for smart contact lenses
Source: University of Surrey (U.K.), via ScienceDaily
Published: January 6, 2021
![]() |
Optical transmittance test and in vitro cytotoxicity test of the smart contact lens |
My rating of this study: ⭐
Guo S, Wu K, Li C, et al. "Integrated contact lens sensor system based on multifunctional ultrathin MoS2 transistors." Matter. 4(3):969-985. 3 March 2021. https://doi.org/10.1016/j.matt.2020.12.002
Tuesday, January 12, 2021
Early Detection of Cognitive Decline in Type 1 Diabetics
Article: Routine eye scans may give clues to cognitive decline in diabetes
Source: Joslin Diabetes Center at Harvard Medical School, via ScienceDaily
Published: January 4, 2021
Ocular Coherence Tomography (OCT) and its most recent additional function of angiography (OCTA) have been explored in recent years as a means of early detection of neurodegenerative diseases such as Alzheimer's. The retina, being an extension of the brain (specifically the diencephalon), allows for a unique, noninvasive, and comparatively inexpensive view into conditions that affect the central nervous system. What was new to me, i.e., what this article introduced me to, is the potential connection between diabetes and Alzheimer's disease. The researchers found associations between proliferative diabetic retinopathy (PDR) and certain memory and psychomotor tasks. The small and somewhat cloistered study, comprising 129 participants, investigated the link for people with Type 1 diabetes, but the researchers plan on future studies for the larger population of people who are affected by Type 2 diabetes.
My rating of this study: ⭐
Fickweiler W, Wolfson EA, Paniagua SM, et al. "Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes." The Journal of Clinical Endocrinology & Metabolism. Published online 30 December 2020. https://doi.org/10.1210/clinem/dgaa921
Monday, January 11, 2021
In the News
Article: Dr. TikTok, Dr. Google, and You
Publication: EyeNet (American Academy of Ophthalmology)
Published: c. January 6, 2021
This blog is specialized in commentary about more exoteric interest in eye care, that is, developments that reach media attention and subsequently the public. Publications by magazines and journals in ophthalmology and optometry are of great interest to a trainee, but the magnitude and the beauty of such information should not be the purview of this review. That being said, I realized retroactively that my first commentary about an article related to eye care published this year was an opinion piece in EyeNet, a publication of the American Academy of Ophthalmology. As this is an archive of my thoughts, my journey, as much as it is a repository of news articles, I wanted to record those words here as well. It marked a very personally meaningful topic and discussion.
Friday, January 1, 2021
Dear Reader
Welcome to Review of Optology
In the interest of supplementing eye care presence, unarguably a source of optimism during challenging times, I have started this personal blog. There are more established magazines in ophthalmology and optometry for a more esoteric audience of eye care providers. This blog serves as an archive of research progress in eye care that reaches media attention, the public, in 2021. As an aspiring clinician/physician-scientist, I think it is beneficial to be informed about the kind of eye care exposure that reaches patients, in order to answer their questions in a more quotidian way. And as with any endeavor that contains a personal touch, this blog also documents my growing familiarity with the field, and my thoughts about it during an early point in my career. I take care to convey information accurately and with citations where appropriate, but take these words with a grain of salt as coming from a student who is still training and not yet licensed. If you do find errors, please leave a comment so that they may be revised accordingly. Happy reading.